Investors who worry that rising GLP-1 drug usage has impaired salty snack sales might be pointing the finger at the wrong culprit.
Communicating your story to the Street
Investors who worry that rising GLP-1 drug usage has impaired salty snack sales might be pointing the finger at the wrong culprit.